Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 2
|
pp. 2851–2863
A novel methylation signature predicts inferior outcome of patients with PDAC
Back to article
Figure 10
(10 of 10)
−
100%
+
Figure 10.
Relationship between survival of PDAC patients and top six mutant driver genes.
(
A
) KRAS mutation, (
B
) SMAD4 mutation, (
C
) TGFBR2 mutation, (
D
) TP53 mutation, (
E
) BTBD11 mutation, (
F
) CDKN2A mutation)
